A novel 2D/0D C 3 N 5 /Bi 2 WO 6 S-scheme heterojunction with enhanced structural defects has been designed for the efficient elimination of pharmaceutical antibiotics and Cr( vi ).
No takes yet. Share an insight, caveat, or question.
Li et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: